National Blood Clot Alliance (NBCA) designates Ascension Sacred Heart Pensacola Center of Excellence for VTE Care
PENSACOLA, Fla., March 25, 2025 /PRNewswire/ -- The National Blood Clot Alliance (NBCA) is proud to welcome Ascension Sacred Heart in Pensacola, Florida as the newest NBCA Venous Thromboembolism (VTE) Center of Excellence (COE). This designation recognizes Ascension Sacred Heart's commitment to providing exceptional, patient-centered care in the prevention, diagnosis, and treatment of blood clots.
NBCA VTE Centers of Excellence™ are leading the way in transforming VTE care.According to the Centers for Disease Control and Prevention (CDC), VTE, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a leading cause of preventable hospital death in the United States, affecting approximately 900,000 people annually and resulting in as many as 100,000 deaths each year. Despite its severity, VTE is often underdiagnosed and undertreated, highlighting the critical need for healthcare institutions to prioritize evidence-based, multidisciplinary approaches to VTE care—an effort exemplified by Ascension Sacred Heart Pensacola.
"This designation is a reflection and celebration of the past ten years of treating patients with PE and DVT," said Dr. Rohit Amin, Interventional Cardiologist at Ascension Sacred Heart. "This is a proud moment for our team, hospital, and community to share this incredible milestone."
As a NBCA VTE Center of Excellence™, Ascension Sacred Heart joins a growing network of institutions dedicated to advancing best practices, improving patient safety, and increasing awareness of blood clot prevention and treatment.
"NBCA VTE Centers of Excellence™ are leading the way in transforming VTE care by not only delivering cutting-edge treatment but also fostering prevention, education, and community engagement," said Erin VanDyke, PA-C, Vice President of the NBCA COE Program. "Ascension Sacred Heart's commitment to comprehensive, patient-focused VTE care makes them an exemplary institution, and we are honored to recognize their efforts with this designation."
The NBCA COE program aims to establish a gold standard for blood clot care by partnering with institutions that embrace multidisciplinary collaboration, innovative treatment approaches, a commitment to ongoing education for both patients and healthcare providers, as well as a deep commitment to their communities.
To learn more about the NBCA VTE Centers of Excellence program and its mission to improve outcomes and save lives, visit www.stoptheclot.org.
About the National Blood Clot Alliance (NBCA)
The National Blood Clot Alliance (NBCA) is a nonprofit organization dedicated to advancing the prevention, early diagnosis, and treatment of life-threatening blood clots. Through education, advocacy, and research, NBCA works to empower patients, support healthcare providers, and drive meaningful improvements in VTE care nationwide.
About Ascension Sacred Heart
Ascension Sacred Heart, based in Pensacola, Florida, operates five hospitals and more than 100 other sites of care and employs more than 6,440 associates. In fiscal year 2024, Ascension Sacred Heart provided more than $193 million in community benefit and other care for vulnerable persons. Ascension is a faith-based healthcare organization dedicated to transformation through innovation across the continuum of care. As one of the leading non-profit and Catholic health systems in the U.S., Ascension is committed to delivering compassionate, personalized care to all, with special attention to persons living in poverty and those most vulnerable. In addition to this measurable success, Ascension Sacred Heart Pensacola also features the Regional Heart and Vascular Institute, the largest cardiovascular health center in Northwest Florida. To find a heart specialist near you, call 850-416-4970 or visit the website.
View original content to download multimedia:https://www.prnewswire.com/news-releases/national-blood-clot-alliance-nbca-designates-ascension-sacred-heart-pensacola-center-of-excellence-for-vte-care-302410566.html
SOURCE National Blood Clot Alliance